- Home
- MOLN vs MVST Comparison
MOLN vs MVST Comparison
Compare MOLN & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- MVST
- Stock Information
- Founded
- MOLN 2004
- MVST 2006
- Country
- MOLN Switzerland
- MVST United States
- Employees
- MOLN N/A
- MVST N/A
- Industry
- MOLN
- MVST Industrial Machinery/Components
- Sector
- MOLN
- MVST Miscellaneous
- Exchange
- MOLN Nasdaq
- MVST Nasdaq
- Market Cap
- MOLN 142.6M
- MVST 848.0M
- IPO Year
- MOLN 2021
- MVST N/A
- Fundamental
- Price
- MOLN $3.70
- MVST $3.42
- Analyst Decision
- MOLN Hold
- MVST Strong Buy
- Analyst Count
- MOLN 1
- MVST 1
- Target Price
- MOLN $4.00
- MVST $6.00
- AVG Volume (30 Days)
- MOLN 5.1K
- MVST 4.9M
- Earning Date
- MOLN 11-05-2025
- MVST 11-11-2025
- Dividend Yield
- MOLN N/A
- MVST N/A
- EPS Growth
- MOLN N/A
- MVST N/A
- EPS
- MOLN N/A
- MVST N/A
- Revenue
- MOLN $856,302.00
- MVST $422,605,000.00
- Revenue This Year
- MOLN N/A
- MVST $24.21
- Revenue Next Year
- MOLN $1,000.00
- MVST $31.67
- P/E Ratio
- MOLN N/A
- MVST N/A
- Revenue Growth
- MOLN N/A
- MVST 20.84
- 52 Week Low
- MOLN $3.36
- MVST $0.15
- 52 Week High
- MOLN $7.60
- MVST $4.72
- Technical
- Relative Strength Index (RSI)
- MOLN 50.41
- MVST 66.07
- Support Level
- MOLN $3.69
- MVST $3.18
- Resistance Level
- MOLN $3.79
- MVST $3.45
- Average True Range (ATR)
- MOLN 0.10
- MVST 0.19
- MACD
- MOLN -0.00
- MVST 0.10
- Stochastic Oscillator
- MOLN 43.24
- MVST 92.04
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.